LFCR News

INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - LFCR, LSTA, FSHP and BWIN - IS IT A FAIR DEAL FOR YOU? INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - LFCR, LSTA, FSHP and BWIN - IS IT A FAIR DEAL FOR YOU?PR NewswireNEW YORK, Nov. 3, 2026...

Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders? Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 5, 2026Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions...

EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- FWAC, MGLD, LFCR, and MG EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- FWAC, MGLD, LFCR, and MGPR NewswireNEW YORK, Oct. 3, 2026NEW YORK, Oct. 3, 2026 /PRNewswire/ --Class Action Attorney Juan Monteverde with Monteverde...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Lifecore Biomedical, Inc. (NasdaqGS: LFCR) to Webster Equity Partners. Under the terms of the proposed transaction, shareholders of Lifecore will...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR)PR NewswireNEW YORK, Sept. 29, 2026 NEW YORK, Sept. 29, 2026...

Are LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders? Are LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 29, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC. LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC.PR NewswireMILWAUKEE, Sept. 28, 2026 Lifecore shareholders will receive just$6.28 per share in a...

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Lifecore Biomedical, Inc. (NASDAQ: LFCR) to Webster Equity Partners for $6.28 per share in cash plus one non-tradable contingent value right per share. Halper Sadeh encourages Lifecore shareholders to click here to learn...

(RTTNews) - Lifecore Biomedical, Inc. (LFCR) announced Monday that it has entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, assuming full achievement of certain performance milestones...